Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
about
Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivoHuman LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activityLinks between Human LINE-1 Retrotransposons and Hepatitis Virus-Related Hepatocellular CarcinomaCancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesisAssociations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review)Viral quasispecies evolutionMolecular mechanisms underlying occult hepatitis B virus infection.APOBEC3 Interference during Replication of Viral GenomesHost APOBEC3G protein inhibits HCV replication through direct binding at NS3An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammalsAnalysis of a single-stranded DNA-scanning process in which activation-induced deoxycytidine deaminase (AID) deaminates C to U haphazardly and inefficiently to ensure mutational diversitySelf-cytoplasmic DNA upregulates the mutator enzyme APOBEC3A leading to chromosomal DNA damageImmunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infectionVirus-related liver cirrhosis: molecular basis and therapeutic options.Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathwaysEvolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions.Quantification of unintegrated HIV-1 DNA at the single cell level in vivo.APOBEC4 Enhances the Replication of HIV-1.Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism.Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA.Efficient deamination of 5-methylcytidine and 5-substituted cytidine residues in DNA by human APOBEC3A cytidine deaminase.Human APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death.Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinomaTGF-β suppression of HBV RNA through AID-dependent recruitment of an RNA exosome complex.Hypermutation of ApoB mRNA by rat APOBEC-1 overexpression mimics APOBEC-3 hypermutation.Cancer, Warts, or Asymptomatic Infections: Clinical Presentation Matches Codon Usage Preferences in Human PapillomavirusesAssociation of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma.Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme.APOBEC3 Proteins in Viral Immunity.Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study.RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminaseMolecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptideThe MOV10 helicase inhibits LINE-1 mobility.HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutationsInterleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID)Association between polymorphisms of the APOBEC3G gene and chronic hepatitis B viral infection and hepatitis B virus-related hepatocellular carcinoma.Hepatitis B virus X protein is capable of down-regulating protein level of host antiviral protein APOBEC3G.HBV life cycle and novel drug targets.Recent insights into hepatitis B virus-host interactions.
P2860
Q24305160-8BAEA725-B9B8-48AA-9BC8-96827C90523CQ24625056-AD85ACC1-7DE7-4C5D-8E51-190D2838D608Q26744497-E0941585-F04B-4CA2-AE3B-62E9ACB25CF5Q26766386-9B147051-17BD-493A-BA03-F6D2D4007CE8Q26781812-F1BD90A5-F3AA-4FB7-9644-52ADC6CF49CAQ27013917-02502647-F104-4EEF-AB0B-7853172F59F7Q27686923-D3B9662C-0B91-418B-ADDA-5FEE76FE8E62Q28081195-BA55BD9C-3544-4251-90F4-0E4FE2443D02Q28545012-F6A55304-5047-4CA5-865E-CCE4CA413717Q28713968-5233BC82-8319-4FDF-AE78-947968808FE0Q30502490-C86F3A81-3B58-46D4-B4A8-E5CC2198D352Q33558248-E59FFFAC-D81E-47A1-8EB5-9AC497B21E7EQ33694570-456081FD-EB1F-4C1F-83EF-97491AED3DE8Q33718267-58DB2117-EFB3-4854-BC7F-F75F5806CCD9Q33982561-A4984DCD-0F70-4BE9-B936-75379D4D8C8AQ34137297-8815D260-163E-42E1-9A43-824558B82B21Q34137458-9EF9BEE3-46AE-4168-B965-79FBEC05D35FQ34264608-8736B5E9-F311-4A91-89A8-CC06BC68A869Q34529142-20EC2911-163D-4B4D-BEBC-5C5319E36277Q34720629-6F2349BC-25D0-471F-83B4-E55379711169Q34733579-E3D30F9A-ED09-4138-BFA2-9E15FF43EA18Q34804205-A3D768C1-9EDB-46A0-BD11-A80C45BD326EQ34974240-604AA817-AA47-48C6-99C6-4D0C78070A19Q35029955-55DCD83F-8F54-426D-98EF-510DC67A3CABQ35593692-FA5471D6-F06C-40B0-BA71-3551FC947BD8Q35850930-8EB1C5F0-8B04-4C51-B1AD-C2D4E2D4DAC5Q36023244-EE25918F-88DF-446D-B2E3-9D579DFF1B7DQ36054401-A5E755A1-6643-4957-A586-C8FB52F509DFQ36228069-556F70B8-CFE1-469D-B4E5-82278112C4E0Q36263411-93592F7C-FAD8-4626-A30E-E5CBA8189EFBQ36280421-20D48BE0-E186-4F75-A75A-F5DD716303B5Q36598091-425919F1-4350-4AA2-9043-ED59C86E2238Q36978561-EDD4E3AC-A402-41EE-81DB-89F42BAE5EB4Q37175149-3CDBFDB3-E74A-4C05-A02D-16087D18B1AEQ37254285-07F0FD31-B4BE-484A-8DBB-0BDB710511A4Q37272140-9575A84C-AD18-4CB9-B5AA-9722FC757833Q37586253-98FF5611-B4A8-4CF8-BF44-DFAE840A4735Q37591195-F2D6A97D-2601-4945-9404-39B1CFDEEC18Q37864117-97D36E30-068C-4D15-A225-A609B8B9A453Q38194061-A5E951D5-A898-48D1-A6F3-9465522870C1
P2860
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
@ast
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
@en
type
label
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
@ast
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
@en
prefLabel
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
@ast
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
@en
P2093
P2860
P50
P1433
P1476
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
@en
P2093
Agnès Marchio
Anne Dejean
Denise Guétard
Marie-Ming Aynaud
Michel Henry
Minerva Cervantes-Gonzalez
Pascal Pineau
Rodolphe Suspène
Simon Wain-Hobson
P2860
P304
P356
10.1371/JOURNAL.PPAT.1000928
P577
2010-05-27T00:00:00Z